Marina Skarednova

Marina Skarednova is an accomplished finance professional with extensive experience in various roles within the pharmaceutical industry. Currently serving as Chief Financial Officer and Business Finance Director at STADA Group since November 2020, Skarednova has a strong background in financial planning and analysis, demonstrated during tenure as FP&A Head at Takeda and as Business Planning and Analysis Manager at Sandoz. Expertise includes budget management, P&L analysis, cost control, forecasting model development, and internal control assessments, with a solid foundation in ensuring compliance with IFRS and SOX requirements. Skarednova holds a Master's degree in Economics of Enterprise from Kyiv National Economics University, earned between 2007 and 2012.